These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3162360)

  • 1. Effect of protein binding on drug penetration into blister fluid.
    Shyu WC; Quintiliani R; Nightingale CH; Dudley MN
    Antimicrob Agents Chemother; 1988 Jan; 32(1):128-30. PubMed ID: 3162360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of cefonicid in skin suction blister fluid in healthy volunteers.
    Cruciani M; Concia E; Passarella E; Soncini R
    Int J Clin Pharmacol Res; 1987; 7(3):225-7. PubMed ID: 3596863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serum protein binding and multiple antibiotic doses in the extravascular distribution of ceftizoxime and cefotaxime.
    Gerding DN; Van Etta LL; Peterson LR
    Antimicrob Agents Chemother; 1982 Nov; 22(5):844-7. PubMed ID: 6295269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro bactericidal activity of cefonicid, ceftizoxime, and penicillin against group B streptococci.
    Bayer AS; Morrison JO; Kim KS
    Antimicrob Agents Chemother; 1982 Feb; 21(2):344-6. PubMed ID: 6280602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved method to determine interstitial fluid pharmacokinetics.
    Shyu WC; Quintiliani R; Nightingale CH
    J Infect Dis; 1985 Dec; 152(6):1328-31. PubMed ID: 3864868
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of the new cephalosporins.
    Brogard JM; Comte F
    Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
    Barry AL; Gavan TL; Jones RN; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
    Diagn Microbiol Infect Dis; 1987 May; 7(1):83-7. PubMed ID: 3121242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.
    Dudley MN; Shyu WC; Nightingale CH; Quintiliani R
    Antimicrob Agents Chemother; 1986 Oct; 30(4):565-9. PubMed ID: 3789691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of ceftizoxime compared with that of cefamandole.
    Neu HC; Srinivasan S
    Antimicrob Agents Chemother; 1981 Sep; 20(3):366-9. PubMed ID: 6272631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of cefonicid into human breast milk and various body fluids and tissues.
    Lou MA; Wu YH; Jacob LS; Pitkin DH
    Rev Infect Dis; 1984; 6 Suppl 4():S816-20. PubMed ID: 6522923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea.
    Korting HC; Schäfer-Korting M; Haag R; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):218-20. PubMed ID: 6325353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime.
    Vallée F; LeBel M
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2057-64. PubMed ID: 1759827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of cefonicid in orthopedic surgery patients.
    Ackerman BH; Trang JM; Nelson CL; Pearce CE; Manning JT; Harrison BH
    Drug Intell Clin Pharm; 1988 Nov; 22(11):864-8. PubMed ID: 3234250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
    Chemioterapia; 1987 Jun; 6(2 Suppl):243-6. PubMed ID: 3509398
    [No Abstract]   [Full Text] [Related]  

  • 15. An overview of pharmacokinetics.
    Cutler RE
    Rev Infect Dis; 1984; 6 Suppl 4():S803-8. PubMed ID: 6522921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefonicid in serum and its penetration into lung tissue, bronchial mucosa and pleura.
    Furlan G; Besa G; Broccali G; Gusmitta A
    Int J Clin Pharmacol Res; 1989; 9(1):49-53. PubMed ID: 2707925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison study of the kinetics of ceftizoxime penetration into extravascular spaces with known surface area/volume ratio in vitro and in vivo in rabbits.
    Van Etta LL; Fasching CE; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1983 Jan; 23(1):49-53. PubMed ID: 6299185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue penetration and half-life of cefonicid.
    Nightingale CH; Quintiliani R; Dudley MN; Gough P; Hickingbotham M; Jordan NS; Rose D; Toscani M
    Rev Infect Dis; 1984; 6 Suppl 4():S821-8. PubMed ID: 6522924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefodizime penetration into skin suction blister fluid following a single intravenous dose.
    Schäfer-Korting M; Korting HC; Maass L; Klesel N; Grigoleit HG; Mutschler E
    Eur J Clin Pharmacol; 1986; 30(3):295-8. PubMed ID: 3732363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery.
    Dudley MN; Nightingale CH; Drezner AD; Low HB; Quintiliani R
    Antimicrob Agents Chemother; 1984 Sep; 26(3):347-50. PubMed ID: 6334490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.